{"count": 8, "results": [{"_id": "32079861", "pmid": 32079861, "title": "Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.", "journal": "Am J Gastroenterol", "authors": ["Vijayaraghavan R", "Jindal A", "Arora V", "Choudhary A", "Kumar G", "Sarin SK"], "date": "2020-05-01T00:00:00Z", "doi": "10.14309/ajg.0000000000000551", "meta_date_publication": "2020 May", "meta_volume": "115", "meta_issue": "5", "meta_pages": "729-737", "score": 50266.453, "text_hl": "Hemodynamic Effects of Adding @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ to @CHEMICAL_Carvedilol @CHEMICAL_MESH:D000077261 @@@Carvedilol@@@ for Primary Prophylaxis of @<m>DISEASE_Varicose_Veins</m> @DISEASE_MESH:D014648 @@@Variceal Bleeding@@@: A Randomized Controlled Trial.", "citations": {"NLM": "Vijayaraghavan R, Jindal A, Arora V, Choudhary A, Kumar G, Sarin SK. Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial. Am J Gastroenterol. 2020 May;115(5):729-737. PMID: 32079861", "BibTeX": "@article{32079861, title={Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.}, author={Vijayaraghavan R and Jindal A and Arora V and Choudhary A and Kumar G and Sarin SK}, journal={Am J Gastroenterol}, volume={115}, number={5}, pages={729-737}}"}}, {"_id": "34366626", "pmid": 34366626, "pmcid": "PMC8326251", "title": "Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy", "journal": "World J Gastroenterol", "authors": ["Muñoz AE", "Pollarsky FD", "Marino M", "Cartier M", "Vázquez H", "Salgado P", "Romero G"], "date": "2021-07-28T00:00:00Z", "doi": "10.3748/wjg.v27.i28.4639", "meta_date_publication": "2021 Jul 28", "meta_volume": "27", "meta_issue": "28", "meta_pages": "4639-4652", "score": 50261.977, "text_hl": "In @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Varicose_Veins</m> @DISEASE_MESH:D014648 @@@variceal bleeding@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was added to standard prophylaxis to prevent rebleeding : NSBBs and band ligation. ", "citations": {"NLM": "Muñoz AE, Pollarsky FD, Marino M, Cartier M, Vázquez H, Salgado P, Romero G. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy World J Gastroenterol. 2021 Jul 28;27(28):4639-4652. PMID: 34366626", "BibTeX": "@article{34366626, title={Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy}, author={Muñoz AE and Pollarsky FD and Marino M and Cartier M and Vázquez H and Salgado P and Romero G}, journal={World J Gastroenterol}, volume={27}, number={28}, pages={4639-4652}}"}}, {"_id": "40736696", "pmid": 40736696, "title": "Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial.", "journal": "Am J Gastroenterol", "authors": ["Rana R", "Tabish M", "Agarwal S", "Bayye R", "Ahmed S", "Gunjan D", "Sharma S", "Saraya A"], "date": "2025-07-31T00:00:00Z", "doi": "10.14309/ajg.0000000000003689", "meta_date_publication": "2025 Jul 31", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50260.176, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ addition to standard of care improves long-term survival in @SPECIES_9606 @@@patients@@@ with @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@cirrhosis@@@ after @<m>DISEASE_Varicose_Veins</m> @DISEASE_MESH:D014648 @@@variceal bleed@@@: An open label randomized controlled trial.", "citations": {"NLM": "Rana R, Tabish M, Agarwal S, Bayye R, Ahmed S, Gunjan D, Sharma S, Saraya A. Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial. Am J Gastroenterol. 2025 Jul 31;():. PMID: 40736696", "BibTeX": "@article{40736696, title={Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial.}, author={Rana R and Tabish M and Agarwal S and Bayye R and Ahmed S and Gunjan D and Sharma S and Saraya A}, journal={Am J Gastroenterol}}"}}, {"_id": "27713045", "pmid": 27713045, "title": "Uncertain Benefits of Simvastatin in the Treatment of Patients With Variceal Hemorrhage.", "journal": "Gastroenterology", "authors": ["Chaudhry T", "Dillon A", "Rowe IA"], "date": "2016-11-01T00:00:00Z", "doi": "10.1053/j.gastro.2016.06.057", "meta_date_publication": "2016 Nov", "meta_volume": "151", "meta_issue": "5", "meta_pages": "1035", "score": 50079.19, "text_hl": "Uncertain Benefits of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in the Treatment of @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Varicose_Veins</m> @DISEASE_MESH:D014648 @@@Variceal Hemorrhage@@@.", "citations": {"NLM": "Chaudhry T, Dillon A, Rowe IA. Uncertain Benefits of Simvastatin in the Treatment of Patients With Variceal Hemorrhage. Gastroenterology. 2016 Nov;151(5):1035. PMID: 27713045", "BibTeX": "@article{27713045, title={Uncertain Benefits of Simvastatin in the Treatment of Patients With Variceal Hemorrhage.}, author={Chaudhry T and Dillon A and Rowe IA}, journal={Gastroenterology}, volume={151}, number={5}, pages={1035}}"}}, {"_id": "26774179", "pmid": 26774179, "title": "Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.", "journal": "Gastroenterology", "authors": ["Abraldes JG", "Villanueva C", "Aracil C", "Turnes J", "Hernandez-Guerra M", "Genesca J", "Rodriguez M", "Castellote J", "García-Pagán JC", "Torres F", "Calleja JL", "Albillos A", "Bosch J", "BLEPS Study Group"], "date": "2016-05-01T00:00:00Z", "doi": "10.1053/j.gastro.2016.01.004", "meta_date_publication": "2016 May", "meta_volume": "150", "meta_issue": "5", "meta_pages": "1160-1170.e3", "score": 50064.938, "text_hl": "Addition of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ to Standard Therapy for the Prevention of @<m>DISEASE_Varicose_Veins</m> @DISEASE_MESH:D014648 @@@Variceal@@@ Rebleeding Does Not Reduce Rebleeding but Increases Survival in @SPECIES_9606 @@@Patients@@@ With @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@Cirrhosis@@@.", "citations": {"NLM": "Abraldes JG, Villanueva C, Aracil C, Turnes J, Hernandez-Guerra M, Genesca J, Rodriguez M, Castellote J, García-Pagán JC, Torres F, Calleja JL, Albillos A, Bosch J, BLEPS Study Group. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. Gastroenterology. 2016 May;150(5):1160-1170.e3. PMID: 26774179", "BibTeX": "@article{26774179, title={Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.}, author={Abraldes JG and Villanueva C and Aracil C and Turnes J and Hernandez-Guerra M and Genesca J and Rodriguez M and Castellote J and García-Pagán JC and Torres F and Calleja JL and Albillos A and Bosch J and BLEPS Study Group}, journal={Gastroenterology}, volume={150}, number={5}, pages={1160-1170.e3}}"}}, {"_id": "16465063", "pmid": 16465063, "title": "HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins.", "journal": "Eur Surg Res", "authors": ["Nomura S", "Yoshimura K", "Akiyama N", "Mikamo A", "Furutani A", "Aoki H", "Matsuzaki M", "Hamano K"], "date": "2005-11-01T00:00:00Z", "doi": "10.1159/000090339", "meta_date_publication": "2005 Nov-Dec", "meta_volume": "37", "meta_issue": "6", "meta_pages": "370-8", "score": 50060.508, "text_hl": "Both @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ strikingly suppressed @GENE_MMP9 @GENE_4318 @@@MMP-9@@@ activity in ex vivo culture of @<m>DISEASE_Varicose_Veins</m> @DISEASE_MESH:D014648 @@@varicose veins@@@. ", "citations": {"NLM": "Nomura S, Yoshimura K, Akiyama N, Mikamo A, Furutani A, Aoki H, Matsuzaki M, Hamano K. HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins. Eur Surg Res. 2005 Nov-Dec;37(6):370-8. PMID: 16465063", "BibTeX": "@article{16465063, title={HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins.}, author={Nomura S and Yoshimura K and Akiyama N and Mikamo A and Furutani A and Aoki H and Matsuzaki M and Hamano K}, journal={Eur Surg Res}, volume={37}, number={6}, pages={370-8}}"}}, {"_id": "26321186", "pmid": 26321186, "title": "Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.", "journal": "Dig Liver Dis", "authors": ["Pollo-Flores P", "Soldan M", "Santos UC", "Kunz DG", "Mattos DE", "da Silva AC", "Marchiori RC", "Rezende GF"], "date": "2015-11-01T00:00:00Z", "doi": "10.1016/j.dld.2015.07.156", "meta_date_publication": "2015 Nov", "meta_volume": "47", "meta_issue": "11", "meta_pages": "957-63", "score": 50058.023, "text_hl": "@SPECIES_9606 @@@Patients@@@ with medium/large @<m>DISEASE_Varicose_Veins</m> @DISEASE_MESH:D014648 @@@oesophageal varices@@@ and previous @<m>DISEASE_Varicose_Veins</m> @DISEASE_MESH:D014648 @@@variceal bleeding@@@ had a higher response rate to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Pollo-Flores P, Soldan M, Santos UC, Kunz DG, Mattos DE, da Silva AC, Marchiori RC, Rezende GF. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial. Dig Liver Dis. 2015 Nov;47(11):957-63. PMID: 26321186", "BibTeX": "@article{26321186, title={Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.}, author={Pollo-Flores P and Soldan M and Santos UC and Kunz DG and Mattos DE and da Silva AC and Marchiori RC and Rezende GF}, journal={Dig Liver Dis}, volume={47}, number={11}, pages={957-63}}"}}, {"_id": "29064029", "pmid": 29064029, "title": "The portal hypertension syndrome: etiology, classification, relevance, and animal models.", "journal": "Hepatol Int", "authors": ["Bosch J", "Iwakiri Y"], "date": "2018-02-01T00:00:00Z", "doi": "10.1007/s12072-017-9827-9", "meta_date_publication": "2018 Feb", "meta_volume": "12", "meta_issue": "Suppl 1", "meta_pages": "1-10", "score": 50041.195, "text_hl": "Treatment is based on the same principles (healthy life style..) associated with administration of NSBBs in combination if possible with endoscopic band ligation if there has been @<m>DISEASE_Varicose_Veins</m> @DISEASE_MESH:D014648 @@@variceal bleeding@@@, and complemented with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ administration (20-40 mg per day in Child-Pugh A/B, 10-20 mg in Child C). ", "citations": {"NLM": "Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int. 2018 Feb;12(Suppl 1):1-10. PMID: 29064029", "BibTeX": "@article{29064029, title={The portal hypertension syndrome: etiology, classification, relevance, and animal models.}, author={Bosch J and Iwakiri Y}, journal={Hepatol Int}, volume={12}, number={Suppl 1}, pages={1-10}}"}}]}